Researchers in the U.K. have found that an ultrasound-guided steroid and anesthetic injection can alleviate the pain and disability affecting soccer players with posterior ankle impingement. The minimally invasive treatment could help players recover pain-free mobility and return to the pitch sooner than conventional treatment would allow.
Researchers in the U.K. have found that an ultrasound-guided steroid and anesthetic injection can alleviate the pain and disability affecting soccer players with posterior ankle impingement. The minimally invasive treatment could help players recover pain-free mobility and return to the pitch sooner than conventional treatment would allow.
Soccer players risk several types of injuries. Inversion of the posterior talofibular ligament usually affects players who are tackled while standing in a neutral position. The initial bruising and swelling associated with this lesion may soon disappear, but players may develop posterior ankle pain that makes sprinting, changing direction, or striking the ball extremely painful. These symptoms can keep players from competing and even from training.
"We see many professional athletes with this condition, and we found that the majority of them were showing excellent response to this treatment," said lead investigator Dr. Philip Robinson of St. James University Hospital in Leeds. "We decided to analyze the imaging features and injection results more rigorously for publication."
Robinson and fellow researcher Dr. Steve R. Bollen, an orthopedic surgeon at the Bradford Royal Infirmary, retrospectively reviewed 10 consecutive professional players who underwent MRI followed by sonography-guided injection between 2001 and 2005. These patients had originally sustained an inversion injury of the ankle in the neutral position and subsequently developed posterior talofibular impingement. They tolerated the injection procedure without complications, showed prompt symptom improvement, and were able to return rapidly to competition (AJR 2006;187[1]:W53-58).
The patients had all endured debilitating pain for about a month despite rehabilitation immediately after the initial inversion injury and subsequent treatment with conservative therapy. They underwent clinical examination by an orthopedic surgeon and MRI of the ankle before the physicians applied an ultrasound-guided injection of bupivacaine into the lesion.
All of the patients presented with posterolateral capsule thickening and synovitis involving an intact posterior talofibular ligament. The researchers also found several other minor and sparsely distributed tendon, ligament, and bone lesions.
The patients underwent clinical follow-up for an average time of a little more than two years. All players returned to their previous competitive level within three weeks of injection. Eight players experienced no residual or recurrent symptoms, while two showed recurrence, one at four months and one at six months.
Both players with recurrences underwent repeat ultrasound-guided injection and returned to professional play within three weeks of the second treatment. One subsequently underwent endoscopic resection of the os trigonum and treatment of synovitis during the off season. The second resumed professional activity and remained pain-free for at least five months after the second injection.
The study demonstrated that ankle impingement syndromes, which affect predominantly soft tissue, can respond to the minimally invasive image-guided injection treatment, the researchers said.
"The results of this study mean that patients should have a faster recovery time and may not require arthroscopy," Robinson said.
For more information from the Diagnostic Imaging archives:
MSK MR goes deep to catch hidden football injuries
MR imaging illuminates elbow joint disorders
Imaging of shoulder opens new turf fight for radiologists
Radiologists look over their shoulders, knees, and hips
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.